SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma spurts on reporting 85% jump in Q2 net profit

26 Oct 2012 Evaluate

Ajanta Pharma is currently trading at Rs 420.45, up by 8.75 points or 2.13% from its previous closing of Rs 411.70 on the BSE.

The scrip opened at Rs 417.00 and has touched a high and low of Rs 424.00 and Rs 416.00 respectively. So far 10784 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 5 has touched a 52 week high of Rs 505.00 on 21-Sep-2012 and a 52 week low of Rs 145.58 on 09-Jan-2012.

Last one week high and low of the scrip stood at Rs 424.00 and Rs 372.00 respectively. The current market cap of the company is Rs 964.08 crore.

The promoters holding in the company stood at 72.70% while Institutions and Non-Institutions held 1.34% and 25.97% respectively.

Ajanta Pharma has registered growth of 84.64% in its net profit after tax at Rs 21.88 crore for second quarter ended September 30, 2012 as compared to Rs 11.85 crore for the same quarter in the previous year. Total income from operation has increased by 37.91% at Rs 186.37 crore for quarter under review as compared to Rs 135.14 crore for the quarter ended September 30, 2011.

Ajanta Pharma (APL) is engaged manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.

 

Ajanta Pharma Share Price

2790.15 -37.95 (-1.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×